Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
M.D. Anderson Cancer Center
Cedars-Sinai Medical Center
Changi General Hospital
UNICANCER
MedSIR
University of Sao Paulo
Federation Francophone de Cancerologie Digestive
Dana-Farber Cancer Institute
Peking Union Medical College Hospital
Dana-Farber Cancer Institute
Instituto do Cancer do Estado de São Paulo
Peking Union Medical College Hospital
H. Lee Moffitt Cancer Center and Research Institute
Institut Bergonié
Xiangya Hospital of Central South University
Case Comprehensive Cancer Center
Fudan University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hospices Civils de Lyon
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Yale University
Yale University
Massachusetts General Hospital
GERCOR - Multidisciplinary Oncology Cooperative Group
Peking University
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt-Ingram Cancer Center
University of Jena